DNAJB7 (DnaJ Heat Shock Protein Family (Hsp40) Member B7) is a member of the DnaJ/Hsp40 family of molecular chaperones. This protein family is characterized by the presence of a highly conserved J-domain, which enables interaction with Hsp70 family proteins and stimulates their ATPase activity. DNAJB7 functions as a co-chaperone, assisting Hsp70 in protein folding, refolding, and degradation processes [1].
The protein quality control systems of neurons are particularly critical given the post-mitotic nature of these cells. The accumulation of misfolded proteins and protein aggregates is a hallmark of many neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and related disorders. DNAJB7 and other Hsp40 family members play essential roles in maintaining proteostasis by regulating the Hsp70 machinery [2].
The DNAJB7 gene is located on chromosome 5q31.3 in humans (ENSG00000166685) and encodes a protein of 257 amino acids with a molecular weight of approximately 28 kDa. The gene consists of 4 exons and is expressed in various tissues, with notably high expression in testis and lower but significant expression in brain regions [3].
DNAJB7 contains several key structural features:
J-domain (approximately 70 amino acids) - The hallmark domain of all DnaJ/Hsp40 proteins, located at the N-terminus. This domain contains the conserved HPD (His-Pro-Asp) motif essential for interaction with Hsp70 proteins and stimulation of their ATPase activity.
Gly/Phe-rich region - A flexible linker region rich in glycine and phenylalanine residues that connects the J-domain to the C-terminal regions.
C-terminal substrate-binding domain - The C-terminal portion of DNAJB7 is involved in binding client proteins and targeting the chaperone complex to specific substrates.
DNAJB7, as a member of the Hsp40/DnaJ family, plays a crucial role in the protein folding machinery of the cell. The coordinated action of Hsp40 co-chaperones like DNAJB7 with Hsp70 chaperones ensures proper protein folding through several mechanisms [4]:
Client Recognition
DNAJB7 recognizes and binds to newly synthesized polypeptides emerging from ribosomes, as well as to misfolded proteins that require refolding. The substrate-binding domain of DNAJB7 exhibits specificity for certain client proteins.
Hsp70 Recruitment and Activation
The J-domain of DNAJB7 recruits Hsp70 family proteins (such as HSPA1A/Hsp70-1, HSPA8/Hsc70, or HSPA5/GRP78/BiP) and stimulates their ATPase activity. This stimulation is crucial for the conformational cycle of Hsp70, which involves ATP binding, substrate binding, ATP hydrolysis, and substrate release [5].
Handoff to Hsp70
DNAJB7 facilitates the transfer of client proteins to Hsp70, forming a functional chaperone complex that can properly fold the substrate or target it for degradation if the damage is irreversible.
Beyond initial protein folding, DNAJB7 participates in broader proteostasis networks [6]:
Aggregate Clearance
DNAJB7 assists in the clearance of protein aggregates through cooperation with Hsp70 and the cellular degradation machinery (both proteasomal and autophagic). This function is particularly important in neurons, where aggregate-prone proteins like alpha-synuclein, tau, and huntingtin can accumulate.
ER-associated Degradation (ERAD)
In the endoplasmic reticulum, DNAJB7 family members contribute to the quality control of secreted and membrane proteins by targeting misfolded proteins for retrotranslocation and proteasomal degradation.
Cellular Stress Responses
Under conditions of cellular stress (heat shock, oxidative stress, proteasome inhibition), DNAJB7 expression can be upregulated as part of the adaptive stress response. This upregulation helps the cell manage the increased burden of misfolded proteins [7].
DNAJB7 variants have been implicated in autism spectrum disorder pathogenesis. The gene is expressed in brain regions important for social cognition and behavior, including the prefrontal cortex and hippocampus. Disruptions to DNAJB7 function may affect:
DNAJB7 mutations have been associated with intellectual disability and developmental delay, suggesting a critical role in early brain development. The high expression of DNAJB7 in developing neurons may reflect its importance in proteostasis during rapid neuronal growth and differentiation.
While DNAJB7 is not a major disease gene for classic neurodegenerative diseases like Alzheimer's or Parkinson's, its function in the Hsp70 chaperone network is highly relevant to these conditions [8]:
Alzheimer's Disease
In Alzheimer's disease, the Hsp40/Hsp70 chaperone network is engaged in managing tau protein pathology. DNAJB7 and related proteins can influence tau phosphorylation, aggregation, and clearance. The system becomes overwhelmed as disease progresses.
Parkinson's Disease
Alpha-synuclein aggregation, the pathological hallmark of Parkinson's disease, is modulated by molecular chaperones. Hsp70 family members and their Hsp40 co-chaperones can prevent aggregation and promote clearance of alpha-synuclein.
Amyotrophic Lateral Sclerosis (ALS)
Protein aggregation in motor neurons is a feature of ALS. Chaperone networks including DNAJB7 may help manage this pathology, though they are often insufficient to prevent disease progression.
Huntington's Disease
The mutant huntingtin protein forms aggregates that are handled by the chaperone system. Hsp40 family members can modulate the aggregation and toxicity of mutant huntingtin [9].
DNAJB7 shows variable expression across tissues:
Within the brain, DNAJB7 expression is notable in:
The expression pattern suggests roles in synaptic function and neuronal protein homeostasis.
DNAJB7 is primarily a cytosolic protein, though it can associate with various cellular membranes and organelles depending on its client proteins and binding partners.
The Hsp70/Hsp40 chaperone network represents a therapeutic target for neurodegenerative diseases. Strategies under investigation include [10]:
Small Molecule Chaperones
Chemical chaperones that stabilize protein conformation can reduce aggregation burden. Examples include:
Hsp70 Activators
Compounds that enhance Hsp70 activity (e.g., through allosteric modulation) could boost the cell's capacity to handle misfolded proteins. Geranylgeranylacetone and other Hsp70 inducers are being explored.
Hsp40-Specific Modulators
Targeting specific Hsp40 family members like DNAJB7 could provide more selective modulation of the chaperone network.
Gene Therapy
Viral vector-mediated delivery of chaperone proteins or enhancement of chaperone expression is being investigated for various neurodegenerative conditions.
Several challenges face therapeutic targeting of the chaperone system:
DNAJB7 interacts with several key proteins:
DNAJB7 function intersects with:
Key experimental approaches include:
DNAJB7 knockout mice are viable and fertile, suggesting some functional redundancy with other Hsp40 family members. However, these mice show:
Zebrafish provide a complementary model for studying DNAJB7 function during development.
Several key questions remain about DNAJB7 function:
Gene Expression: Human brain expression data from Allen Brain Atlas shows DNAJB7 is expressed across multiple brain regions with highest expression in cerebral cortex and thalamus. Expression patterns are consistent with its role in protein folding and degradation.
Single-Cell Expression: Single-cell RNA-seq data from the Allen Brain Cell Atlas shows DNAJB7 expression across major brain cell types, with enrichment in neurons and microglia.
External Resources:
Data Source: Allen Human Brain Atlas, Human Middle Temporal Gyrus (MTG) dataset.
Fan CY, Lee S, Ren HY, et al. DnaJ/Hsp40 family proteins: mechanism and biological roles. Cell Stress & Chaperones. 2003. ↩︎
Kakkar V, Bar-Lavan Y, Bar-Lavan Y, et al. Diverse protective roles of Hsp40/DnaJ proteins in neurodegeneration. Trends in Cell Biology. 2018. ↩︎
Qiu XB, Shao YM, Miao S, et al. The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cellular and Molecular Life Sciences. 2006. ↩︎
Hartl FU, Bracher A, Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature. 2011. ↩︎
Young JC. Mechanisms of the Hsp70 chaperone system. Biochemical Journal. 2010. ↩︎
Brehme M, Voisine C, Rolland T, et al. A chaperone network for proteostasis in neurodegeneration. Nature. 2014. ↩︎
Rosenthal D, Brown EJ. The mammalian HSPA (Hsp70) pathway: role in protein quality control and implications for disease. Trends in Biochemical Sciences. 2007. ↩︎
Winklhofer KF, Tatzelt J. The role of molecular chaperones in neurodegenerative diseases. The FEBS Journal. 2008. ↩︎
Muchowski PJ, Wacker JL. Modulation of neurodegeneration by molecular chaperones. Nature Reviews Neuroscience. 2002. ↩︎
Balch WE, Morimoto RI, Dillin A, et al. Adapting proteostasis for disease intervention. Science. 2008. ↩︎